Author

Xiaoliang Chen

Institution: Shanxi Datong University

Observed institution: Shanxi Datong University

ORCID: 0000-0001-8477-6815

Observed ORCID: 0000-0001-8477-6815

OpenAlex ID: A5047552216

A label-free fluorescent aptasensor based on HCR and G-quadruplex DNAzymes for the detection of prostate-specific antigen

2020 · Ruirui Zhao, Lu Zhao, et al. · The Analyst · 23

Aptamer-Modified Nb 2 C Multifunctional Nanomedicine for Targeted Photothermal/Chemotherapy Combined Therapy of Tumor

2024 · Meiqing Liu, Lu Zhao, et al. · Molecular Pharmaceutics · 21

Knockdown of RhoA Expression Reverts Enzalutamide Resistance via the p38 MAPK Pathway in Castration-resistant Prostate Cancer

2022 · Xiaoliang Chen, Lili Yin, et al. · Recent Patents on Anti-Cancer Drug Discovery · 7

Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs

2026 · Aiai Wang, Hui Xu, et al. · Molecular Pharmaceutics

[Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration‑resistant prostate cancer

2026 · Xiaoliang Chen, Lili Yin, et al. · Oncology Letters

Aptamer-Functionalized AuNR Nanoplatform for Active Targeted Chemo-Photothermal Therapy of Tumor

2026 · Hui Xu, Lu Zhao, et al. · Bioconjugate Chemistry

Works count: 6

Citation count: 51

H-index: 3

I10-index: 2